MindMaze and Vibra Announce Breakthrough Neurorehab Results

Two-year study shows technology-enabled, high-intensity therapy improves outcomes in inpatient rehab settings.

Mar. 31, 2026 at 8:19am

Got story updates? Submit your updates here. ›

MindMaze Therapeutics and Vibra Healthcare announced the results of a two-year multi-site quality improvement program demonstrating real-world evidence that the integration of technology-enabled, high-dose therapy into standard inpatient rehabilitation can significantly improve patient outcomes.

Why it matters

This study provides promising data on the benefits of incorporating advanced digital therapeutics and high-intensity rehabilitation protocols into traditional inpatient care, which could lead to better recovery for patients dealing with neurological conditions and injuries.

The details

The program integrated MindMaze's digital rehabilitation platform and high-intensity therapy protocols into Vibra Healthcare's inpatient rehabilitation facilities. Researchers found this approach led to improved functional outcomes, reduced length of stay, and higher patient satisfaction compared to standard rehabilitation care.

  • The two-year multi-site quality improvement program was conducted from 2024 to 2026.

The players

MindMaze Therapeutics

A Swiss digital therapeutics company that develops technology-enabled rehabilitation solutions.

Vibra Healthcare

A Pennsylvania-based operator of inpatient rehabilitation hospitals and long-term acute care hospitals.

Got photos? Submit your photos here. ›

What’s next

MindMaze and Vibra plan to expand the program to additional rehabilitation facilities in the coming year.

The takeaway

The successful integration of advanced digital therapeutics and high-intensity protocols into traditional inpatient rehabilitation demonstrates the potential for technology to enhance patient outcomes and transform the delivery of care for those recovering from neurological conditions.